On the other hand, RPS6 was reported to cause metabolic abnormalities in type 2 diabetic patients and may also play a role in reducing focal adhesion through the PI3K-Akt-mTOR signaling pathway. This evidence concerns the gene RPS6 and type 2 diabetes mellitus.